2012
-
BME researchers look at novel therapeutic approach to prevent hardened heart valves
Merryman Heart valve disease has few non-surgical therapeutic options. To develop strategies for treating and preventing heart valve disease, W. David Merryman, Ph.D., assistant professor of Biomedical Engineering, and colleagues are studying the cellular signaling that leads to calcification (hardening) of the aortic valve. Previous studies have shown that… Read MoreDec. 28, 2012
-
Goldfarb among 10 electronics visionaries to watch: EE Times
Merryman Heart valve disease has few non-surgical therapeutic options. To develop strategies for treating and preventing heart valve disease, W. David Merryman, Ph.D., assistant professor of Biomedical Engineering, and colleagues are studying the cellular signaling that leads to calcification (hardening) of the aortic valve. Previous studies have shown that… Read MoreDec. 21, 2012
-
Bottle rockets pique middle schoolers interest in engineering
Merryman Heart valve disease has few non-surgical therapeutic options. To develop strategies for treating and preventing heart valve disease, W. David Merryman, Ph.D., assistant professor of Biomedical Engineering, and colleagues are studying the cellular signaling that leads to calcification (hardening) of the aortic valve. Previous studies have shown that… Read MoreDec. 21, 2012
-
Mechanical engineering alum is rising business leader in Ohio
Merryman Heart valve disease has few non-surgical therapeutic options. To develop strategies for treating and preventing heart valve disease, W. David Merryman, Ph.D., assistant professor of Biomedical Engineering, and colleagues are studying the cellular signaling that leads to calcification (hardening) of the aortic valve. Previous studies have shown that… Read MoreDec. 14, 2012
-
Engineering school benefactor William W. Featheringill dies
Merryman Heart valve disease has few non-surgical therapeutic options. To develop strategies for treating and preventing heart valve disease, W. David Merryman, Ph.D., assistant professor of Biomedical Engineering, and colleagues are studying the cellular signaling that leads to calcification (hardening) of the aortic valve. Previous studies have shown that… Read MoreDec. 11, 2012
-
New faculty: Rizia Bardhan finds solutions at the nanoscale
Merryman Heart valve disease has few non-surgical therapeutic options. To develop strategies for treating and preventing heart valve disease, W. David Merryman, Ph.D., assistant professor of Biomedical Engineering, and colleagues are studying the cellular signaling that leads to calcification (hardening) of the aortic valve. Previous studies have shown that… Read MoreDec. 11, 2012
-
Dean Philippe Fauchet’s vision is a focus on human needs
Merryman Heart valve disease has few non-surgical therapeutic options. To develop strategies for treating and preventing heart valve disease, W. David Merryman, Ph.D., assistant professor of Biomedical Engineering, and colleagues are studying the cellular signaling that leads to calcification (hardening) of the aortic valve. Previous studies have shown that… Read MoreDec. 7, 2012
-
NSF grant to help engineers accelerate development of medical capsule robots
Merryman Heart valve disease has few non-surgical therapeutic options. To develop strategies for treating and preventing heart valve disease, W. David Merryman, Ph.D., assistant professor of Biomedical Engineering, and colleagues are studying the cellular signaling that leads to calcification (hardening) of the aortic valve. Previous studies have shown that… Read MoreDec. 6, 2012
-
Surgery and engineering initiative offers funds to develop interventional medical devices
Merryman Heart valve disease has few non-surgical therapeutic options. To develop strategies for treating and preventing heart valve disease, W. David Merryman, Ph.D., assistant professor of Biomedical Engineering, and colleagues are studying the cellular signaling that leads to calcification (hardening) of the aortic valve. Previous studies have shown that… Read MoreDec. 5, 2012
-
Jeff Olmstead heeds call of the energy business
Merryman Heart valve disease has few non-surgical therapeutic options. To develop strategies for treating and preventing heart valve disease, W. David Merryman, Ph.D., assistant professor of Biomedical Engineering, and colleagues are studying the cellular signaling that leads to calcification (hardening) of the aortic valve. Previous studies have shown that… Read MoreDec. 4, 2012